Anouk T N van Diepen1, Sadie van Esch2, Dirk G Struijk3, Raymond T Krediet4. 1. Division of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands a.t.vandiepen@amc.uva.nl. 2. St. Elisabeth Hospital, Department of Nephrology and Internal Medicine, Tilburg, The Netherlands. 3. Division of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands Dianet, Amsterdam-Utrecht, The Netherlands. 4. Division of Nephrology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Abstract
UNLABELLED: ♦ BACKGROUND AND OBJECTIVE: Little or no clinical evidence is available on the association between glucose exposure and peritoneal host defense in peritoneal dialysis (PD) patients. The objective of the present study was to quantify the exposure to glucose during the first year on PD and investigate the association with subsequent peritonitis. ♦ METHODS: We analyzed prospectively collected demographic and peritonitis data from incident adult PD patients between 1990 and 2010. For the present study, we conducted a review of both in- and outpatient medical records of all patients to obtain their day-to-day dialysis schemes during the first year on PD. From these data, the average exposure to glucose was quantified. The exposure was stratified into low- and high-glucose groups based on the median, analyzed per standard deviation and in quartiles. Cox proportional hazard models were used to calculate crude and adjusted hazard ratios (HRs) and 95% confidence intervals for the association between glucose exposure and peritonitis. Adjustments were made for age, sex, primary kidney disease, diabetes mellitus, Davies comorbidity score and the treatment period. ♦ RESULTS: In total, 230 patients were included in the study of whom 151 (66%) experienced a first peritonitis episode. The median follow-up time was 2.6 years (interquartile range [IQR]: 1.9 - 3.8) in the low-glucose group and 3.1 (IQR: 2.1 - 4.2) in the high-glucose group. After adjustment for confounding factors, no association between high glucose exposure and the risk of peritonitis was found (HR: 0.81; 0.55 - 1.17). No association was present when glucose exposure was analyzed per standard deviation (SD) (HR: 0.98; 0.79 - 1.21) or patient quartiles were applied. No association was identified between glucose exposure and severe peritonitis, Staphylococcus aureus peritonitis, or a peritonitis episode that lasted more than 14 days. ♦ CONCLUSIONS: Exposure to glucose is not associated with an increased risk of peritonitis. The equilibrium between glycemic harm to peritoneal host defense and detrimental effects of glucose on invading microorganisms may determine the susceptibility to peritoneal infection.
UNLABELLED: ♦ BACKGROUND AND OBJECTIVE: Little or no clinical evidence is available on the association between glucose exposure and peritoneal host defense in peritoneal dialysis (PD) patients. The objective of the present study was to quantify the exposure to glucose during the first year on PD and investigate the association with subsequent peritonitis. ♦ METHODS: We analyzed prospectively collected demographic and peritonitis data from incident adult PDpatients between 1990 and 2010. For the present study, we conducted a review of both in- and outpatient medical records of all patients to obtain their day-to-day dialysis schemes during the first year on PD. From these data, the average exposure to glucose was quantified. The exposure was stratified into low- and high-glucose groups based on the median, analyzed per standard deviation and in quartiles. Cox proportional hazard models were used to calculate crude and adjusted hazard ratios (HRs) and 95% confidence intervals for the association between glucose exposure and peritonitis. Adjustments were made for age, sex, primary kidney disease, diabetes mellitus, Davies comorbidity score and the treatment period. ♦ RESULTS: In total, 230 patients were included in the study of whom 151 (66%) experienced a first peritonitis episode. The median follow-up time was 2.6 years (interquartile range [IQR]: 1.9 - 3.8) in the low-glucose group and 3.1 (IQR: 2.1 - 4.2) in the high-glucose group. After adjustment for confounding factors, no association between high glucose exposure and the risk of peritonitis was found (HR: 0.81; 0.55 - 1.17). No association was present when glucose exposure was analyzed per standard deviation (SD) (HR: 0.98; 0.79 - 1.21) or patient quartiles were applied. No association was identified between glucose exposure and severe peritonitis, Staphylococcus aureus peritonitis, or a peritonitis episode that lasted more than 14 days. ♦ CONCLUSIONS: Exposure to glucose is not associated with an increased risk of peritonitis. The equilibrium between glycemic harm to peritoneal host defense and detrimental effects of glucose on invading microorganisms may determine the susceptibility to peritoneal infection.
Authors: Paulus H S Kwakman; Anje A te Velde; Leonie de Boer; Dave Speijer; Christina M J E Vandenbroucke-Grauls; Sebastian A J Zaat Journal: FASEB J Date: 2010-03-12 Impact factor: 5.191
Authors: G A Coles; D J O'Donoghue; N Pritchard; C S Ogg; F M Jani; R Gokal; G C Cancarini; R Maiorca; A Tranaeus; C De Vos; A Hopwood; D Faict Journal: Nephrol Dial Transplant Date: 1998-12 Impact factor: 5.992
Authors: Herma Uiterwijk; Casper F M Franssen; Johanna Kuipers; Ralf Westerhuis; Ferdau L Nauta Journal: Am J Nephrol Date: 2020-02-18 Impact factor: 3.754